Clinical Trial Update: Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating REOLYSIN in combination with paclitaxel and carboplatin for platinum-refractory head and neck squamous cell carcinoma that ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Carcinoma, Squamous Cell of the Head and Neck | Phase 3 | Status: COMPLETED